Clinical Trial Update: A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC [Phase 2]

View source ↗

Summary

Phase II trial evaluating chemotherapy with or without Endostar continuous IV infusion in refractory nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Yun-fei Xia | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN